This drug can reduce breast cancer recurrence
London: Zoledronic acid, a group of drugs, tried out on breast cancers among post-menopausal women has shown promising results.
Mainly used to treat osteoporosis, zoledronic acid is also given to cancer patients to protect against the effects of secondary bone cancer, such as pain and weakness in the bones.
Lab studies have suggested that zoledronic acid might also have direct anti-tumour effects and enhance other chemotherapy treatments.
Led by Robert Coleman, professor at the Weston Park Hospital in Sheffield, Britain, the drug trial recruited 3,360 patients with stage II/III breast cancer from 174 centres.
They were randomised to receive chemotherapy and/or endocrine therapy, with or without zoledronic acid, according to a Weston statement.
An interim analysis confirmed the overall survival rate was 85 percent compared to 79 percent for women who did not receive zoledronic acid.
"This is a small but significant increase," Coleman explains. These findings were presented at the 2011 European Multidisciplinary Cancer Congress.
More from India
More from World
More from Sports
More from Entertaiment
- Delhi Police arrests AAP MLA in the middle of press conference
- Pak grants 91-year-old Indian's last wish - a trip to his ‘ancestral home’
- Bihar: Acid attack on girl in Aurangabad district, victim critical
- MP: Dalit families migrating from village due to hooligans
- Is there any political clash between Akhilesh Yadav and Shivpal Yadav?
- SHOCKING! Islamic State-linked Saudi twin brothers attack own family, stab mother
- Sri Lanka's parliament votes in favour of right to information bill
- WATCH: What a dance! Sizzling performance by IIT-Delhi girls on Sunny Leone's Baby Doll - You'll go mad!
- SHAME! Labourer demands wages; employer beats him to death
- Non-BJP parties plan to boycott PM Narendra Modi's 'Smart Cities Mission' event - Know the reason